Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Oct 1;147(7):1029–1032.

Revised guidelines for booster vaccination against hepatitis B.

D Holton 1
PMCID: PMC1336291  PMID: 1393899

Full text

PDF
1029

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O'Malley P. M., Penley K. A., Altman N. L. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. doi: 10.1056/NEJM198607243150401. [DOI] [PubMed] [Google Scholar]
  2. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O'Malley P. M., Penley K. A., Altman N. L. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. doi: 10.1056/NEJM198607243150401. [DOI] [PubMed] [Google Scholar]
  3. Jilg W., Schmidt M., Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol. 1988 Apr;6(2):201–207. doi: 10.1016/s0168-8278(88)80032-1. [DOI] [PubMed] [Google Scholar]
  4. Jilg W., Schmidt M., Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol. 1988 Apr;6(2):201–207. doi: 10.1016/s0168-8278(88)80032-1. [DOI] [PubMed] [Google Scholar]
  5. Wainwright R. B., McMahon B. J., Bulkow L. R., Hall D. B., Fitzgerald M. A., Harpster A. P., Hadler S. C., Lanier A. P., Heyward W. L. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA. 1989 Apr 28;261(16):2362–2366. [PubMed] [Google Scholar]
  6. Wainwright R. B., McMahon B. J., Bulkow L. R., Parkinson A. J., Harpster A. P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med. 1991 Aug;151(8):1634–1636. [PubMed] [Google Scholar]
  7. Wainwright R. B., McMahon B. J., Bulkow L. R., Parkinson A. J., Harpster A. P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med. 1991 Aug;151(8):1634–1636. [PubMed] [Google Scholar]
  8. Yoshida K., Fujiyama S., Sato T. Persistence of anti-HBs and protective efficacy after administration of hepatitis B vaccine. J Gastroenterol Hepatol. 1990 Mar-Apr;5(2):126–129. doi: 10.1111/j.1440-1746.1990.tb01816.x. [DOI] [PubMed] [Google Scholar]
  9. Yoshida K., Fujiyama S., Sato T. Persistence of anti-HBs and protective efficacy after administration of hepatitis B vaccine. J Gastroenterol Hepatol. 1990 Mar-Apr;5(2):126–129. doi: 10.1111/j.1440-1746.1990.tb01816.x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES